Demonstrates enhanced MRI contrast modulation in pathological settings, suggesting improved imaging outcomes.
Stimuli-responsive MRI agents enable disease-specific imaging by selectively modulating generated contrast in pathological microenvironments. To date, these moieties have been largely limited to those of low signal-to-noise that respond to...
No takes yet. Share an insight, caveat, or question.
Smith et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: